BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26

• Press Releases

  Kairos Pharma, Ltd. Sets Annual Meeting of Shareholder Date and Provides Update on Its Annual Filings

  May 10, 2026

   · 

  3 min read
• Press Releases

  MiNK Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across iNKT Cell Therapy Programs

  May 10, 2026

   · 

  2 min read
• Press Releases

  Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology

  May 10, 2026

   · 

  4 min read
• Press Releases

  FDA Grants Seventh Approval under the National Priority Voucher Pilot Program

  May 10, 2026

   · 

  2 min read
• Press Releases

  Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026

  May 10, 2026

   · 

  4 min read
• Press Releases

  Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 8, 2026

  May 10, 2026

   · 

  1 min read
• Press Releases

  RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow

  May 10, 2026

   · 

  28 min read
• Press Releases

  MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results

  May 10, 2026

   · 

  25 min read
• Press Releases

  SINOVAC Reports Unaudited First Half of 2025 Financial Results

  May 10, 2026

   · 

  20 min read
• Press Releases

  argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG

  May 10, 2026

   · 

  14 min read